Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 18 February 2015 | By Michael Mezher
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has appointed a prominent academic figure, Dr. Peter Nightingale, to be the chair of its newly formed expert group on medical devices—a position intended to help UK regulators strengthen oversight of the UK's medical device sector.
In 2014, an independent review of the UK’s MHRA concluded that the agency needs to bolster its oversight of medical devices and increase its engagement with the medical device clinical community.
The review, headed by Professor Terence Stephenson, chair of the UK Academy of Medical Royal Colleges, was conducted in light of recent highly publicized cases of faulty medical devices in Europe.
For more information on recent medical devices scandals, see our coverage of the PIP breast implant scandal and metal-on-metal hip implants.
The review argues that “MHRA must take devices as seriously as medicines,” and makes 12 recommendations for the agency to improve the safety of medical devices.
One of the key outcomes of the review was the formation of the Devices Expert Advisory Committee (DEAC), which replaces the previous Committee on the Safety of Devices (CSD).
The formation of the DEAC seeks to address some of the criticisms raised in the review of the CSD. Unlike MHRA’s Commission on Human Medicines (CHM), the CSD does not have a statutory basis, and can only provide advice to the agency. The report calls the timeliness of that advice into question, as the CSD only meets three times per year. This means that MHRA typically reacts to crises without CSD input. Also, because the CSD is made up of roughly 400 unpaid members, it is not as agile as the reviewers feel is necessary.
MHRA responded to Stephenson’s review in a press release in July 2014. In the release, MHRA accepted all of the recommendations in the review. The agency said it would establish the DEAC by April 2015 and had begun to recruit a chairperson for the 12 member committee. MRHA said the committee “will be linked to a network of specialist sub-groups and ad-hoc groups to deliver specialist advice” to the agency.
Dr. Peter Nightingale has extensive experience in the medical community. His appointment comes after serving as the president of the Royal College of Anaesthetists and as vice chair of the Academy of Medical Royal Colleges, where Stephenson served as chair.
Nightingale’s appointment was welcomed by MHRA Devices Director John Wilkinson, who said Nightingale’s “will be invaluable in helping the agency as it responds to the demands of the future.”
MHRA Press Release
Tags: DEAC, Devices Expert Advisory Committee, Committee on the Safety of Devices, CSD
Regulatory Focus newsletters
All the biggest regulatory news and happenings.